Bioorganic & Medicinal Chemistry Letters 2001-01-22

Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor.

W T Sing, C L Lee, S L Yeo, S P Lim, M M Sim

Index: Bioorg. Med. Chem. Lett. 11(2) , 91-4, (2001)

Full Text: HTML

Abstract

Arylalkylidene rhodanines 2(a-d) inhibit HCV NS3 protease at moderate concentrations. They are better inhibitors of other serine proteases such as chymotrypsin and plasmin. However, the selectivity of arylmethyliden e rhodanines (8a, 9a) with bulkier and more hydrophobic functional groups increases by 13- and 25-fold towards HCV NS3 protease respectively.

Related Compounds

  • Methyl thioglycola...
  • Rhodanine

Related Articles:

Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.

2014-12-29

[Small 10(24) , 5137-50, (2014)]

Ligand-controlled growth of ZnSe quantum dots in water during Ostwald ripening.

2012-09-11

[Langmuir 28(36) , 12931-40, (2012)]

Simultaneous determination of dimethylarsinic acid and monomethylarsonic acid after derivatization with thioglycol methylate by gas chromatography/mass spectrometry.

1999-01-01

[Rapid Commun. Mass Spectrom. 13(5) , 350-3, (1999)]

Thermochromism of heme adducts of Glycera hemoglobin and some other monomeric heme proteins.

1990-08-01

[J. Inorg. Biochem. 39(4) , 351-69, (1990)]

Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging.

2012-01-01

[Theranostics 2(8) , 757-68, (2012)]

More Articles...